These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
440 related items for PubMed ID: 31116180
1. Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers. Nolan T, Booy R, Marshall HS, Richmond P, Nissen M, Ziegler JB, Baine Y, Traskine M, Jastorff A, Van der Wielen M. Pediatr Infect Dis J; 2019 Jun; 38(6):643-650. PubMed ID: 31116180 [Abstract] [Full Text] [Related]
2. Combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well-tolerated and immunogenic when administered according to the 2,3,4 months schedule with a fourth dose at 12-18 months of age. Habermehl P, Leroux-Roels G, Sänger R, Mächler G, Boutriau D. Hum Vaccin; 2010 Aug; 6(8):640-51. PubMed ID: 20697200 [Abstract] [Full Text] [Related]
8. Long-term antibody persistence after a booster dose of quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in healthy 5-year-old children. Vesikari T, Forsten A, Laudat F, Li P, Van Der Wielen M, Hezareh M, Perez JL, Webber C. Vaccine; 2020 May 08; 38(22):3902-3908. PubMed ID: 32284274 [Abstract] [Full Text] [Related]
12. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study. Vesikari T, Forstén A, Desole MG, Ferrera G, Caubet M, Mesaros N, Boutriau D. Pediatr Infect Dis J; 2013 May 08; 32(5):521-9. PubMed ID: 23190785 [Abstract] [Full Text] [Related]
18. Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults: An Open, Randomized Trial. Baxter R, Baine Y, Kolhe D, Baccarini CI, Miller JM, Van der Wielen M. Pediatr Infect Dis J; 2015 Nov 08; 34(11):1236-43. PubMed ID: 26237742 [Abstract] [Full Text] [Related]
20. Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool Age. Ishola DA, Andrews N, Waight P, Yung CF, Southern J, Bai X, Findlow H, Matheson M, England A, Hallis B, Findlow J, Borrow R, Miller E. Pediatr Infect Dis J; 2015 Aug 08; 34(8):865-74. PubMed ID: 26075813 [Abstract] [Full Text] [Related] Page: [Next] [New Search]